Click to go to DrugInjuryLaw Home


Legal information and news about prescription drug side effects
NuvaRing Case Evaluation Ortho Evra Case Evaluation Fosamax Case Evaluation Avandia Case EvaluationKetek Case Evaluation Zelnorm Case Evaluation Meridia Case Evaluation
Vytorin Case EvaluationZetia Case Evaluation Yasmin Case Evaluation Ocella Case EvaluationYAZ Case Evaluation Levaquin Case Evaluation Byetta Case Evaluation


Free Case Evaluation

News And Information Hub:

YAZ / Yasmin / Beyaz / Safyral / Ocella / Gianvi 

Visit Our New Site >> Drug Side Effects: Legal & Medical Information

 

Gianvi (Generic YAZ), Beyaz, And Safyral Causing Blood Clots In Lung (PE) Or Legs (DVT) Are Cases That Can Get Settlements

While These Claims Against Bayer Are Lesser Known Than YAZ / Yasmin / Ocella Lawsuits They Are Essentially The Same Type Of Drug Injury Legal Claim


Drug injury lawyer Tom Lamb and the Law Offices of Thomas J. Lamb, P.A. are handling personal injury and wrongful death lawsuits against the drug company when a woman developed any of these medical conditions while using YAZ / Yasmin / Beyaz / Safyral / Ocella / Gianvi or shortly thereafter:

Blood Clots
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Stroke
Cerebrovascular Accidents
Heart Attack
Myocardial Infarction
Death

If you or someone you know is interested in possibly filing a claim for legal compensation, we offer a free Case Evaluation for YAZ / Yasmin / Beyaz / Safyral / Ocella / Gianvi.

In the alternative, you can call our toll-free number, (800) 426-9535, to discuss a possible YAZ, Yasmin, Beyaz, Safyral, Ocella, or Gianvi case with attorney Tom Lamb.

 


Here is some medical information about pulmonary embolisms / pulmonary embolus (PE) from the Mayo Clinic and the U.S. National Institute of Health's MedLine Plus.


Here is some medical information about deep vein thrombosis / deep venous thrombosis (DVT) from the Mayo Clinic and the U.S. National Institute of Health's MedLine Plus.

Here is some medical information about strokes, or cerebrovascular accidents (CVA), from the Mayo Clinic and the U.S. National Institute of Health's MedLine Plus.

Here is some medical information about heart attacks, or myocardial infarctions (MI), from the Mayo Clinic and the U.S. National Institute of Health's MedLine Plus.


Drug Injury Watch Blog Posts About Yaz / Yasmin / Beyaz / Safyral / Ocella / Gianvi

During 2013 Bayer Has Had More Than 2000 YAZ / Yasmin Lawsuits For Blood Clots That Are Not Settled

September 2013 Bayer Corporate Report Shows Apparent Progress In Settlement Negotiations, But A Number Of More Serious Cases Are Still Pending

SUMMARY: From the Bayer Stockholders’ Newsletter, Financial Report as of September 30, 2013, Third quarter of 2013:

As of October 18, 2013, Bayer had reached agreements, without admission of liability, to settle the claims of approximately 7,660 claimants in the U.S. for a total amount of about US$1.575 billion. Bayer has only been settling claims in the U.S.for venous clot injuries (deep vein thrombosis or pulmonary embolism).... Such injuries are alleged by about 2,300 of the pending unsettled claimants. Bayer will continue to consider the option of settling such individual lawsuits in the U.S. on a case-by-case basis.

It remains to be seen whether there will be any court trials for YAZ, Yasmin, Ocella, Gianvi, Beyaz, and Safyral lawsuits involving arterial clots, which can cause strokes and other serious side effects. Reportedly, thus far the lawyers for Bayer have refused to negotiate these types of cases.

[Read this article in full at original source]

 

Earlier DRSP Birth Control Pills articles by Tom Lamb on the Drug Injury Watch blog:


YAZ / Yasmin / Ocella / Gianvi Blood Clot Lawsuits That Are Not Settled Yet: Number Increases, Indicating That These Legal Claims Continue To Be Filed In 2013

Legal Claims May Be Possible In California For Gianvi, Zarah, Loryna, Syeda, And Vestura (Generic YAZ / Yasmin) Blood Clot Side Effects Due To Pikerie v. Teva Case Ruling

Summer 2013 Bayer Lawsuits Update: YAZ, Yasmin, Ocella, And Gianvi Lawsuits Continue To Be Settled, With New Cases Being Filed

As Bayer Settlements For YAZ, Yasmin, Ocella, And Gianvi Continue In 2013, Total Payments Will Go Over The $1 Billion Level

Some Newer Contraceptive Methods Such As NuvaRing And YAZ / Yasmin Are Under Increasing Scrutiny Over In Europe

November 2012 Litigation And Settlement Update: YAZ, Yasmin, Ocella, And Gianvi Lawsuits

2012 FDA Report On Beyaz Points Out That Younger Women and Girls Are Most At-Risk For Blood Clots

Bayer Settlements: Gianvi / Ocella / Yasmin / YAZ: July 2012 Update On Drug Injury Lawsuits Filed To Date

Medical Study Finds Link Between YAZ / Yasmin And Irritable Bowel Syndrome (IBS) Coming From Drospirenone (DRSP) Progestin

Bayer Settlements For YAZ / Yasmin Lawsuits Involving Blood Clot Side Effects Like Deep Vein Thrombosis And Pulmonary Embolism

April 2012 Yasmin / YAZ Label Change: FDA Warns About Increased Risk Of Blood Clots Possible Due To Drospirenone

YAZ / Yasmin Litigation Update: 11,300 Lawsuits Have Been Served Upon Bayer As Of February 1, 2012

Yasmin / Safyral / Beyaz: February 2012 Label Change Non-Specific To These Bayer Birth Control Pills

Gianvi Legal Claims Against Drug Company Still Possible Despite Mensing Case Rule Against Generic Drug Injury Lawsuits

YAZ / Yasmin January 2012 Update: Minutes And Transcripts For FDA Advisory Committees 2011 Meeting Now Available Online (And More)

YAZ / Yasmin: December 2011 FDA Advisory Committees Meeting Background Materials Now Available Online

Another Generic YAZ Birth Control Pill Is Approved, Just One Week Before FDA Drug Safety Meeting

Two More Medical Studies Show Increased Risk Of Blood Clots With Use Of YAZ, Yasmin, And Ocella

YAZ / Yasmin / Ocella Update: October 2011 FDA Study Finds Increased Risk Of Blood Clot Side Effects Like DVT, PE, Stroke, And Heart Attack

Women Who Used YAZ / Yasmin / Ocella Are Getting Letters From Aetna Medical Insurance Company


YAZ / Yasmin / Ocella: FDA Study Suggests An Increased Risk Of Blood Clots That Can Cause Side Effects Like Pulmonary Embolism

YAZ / Yasmin / Ocella / Beyaz / Safyral: Drug Safety Regulators Focus On Blood Clot Side Effects


Yasmin / YAZ MDL: First Trial Moved From September 2011 To January 2012 Per Plaintiffs' Request

Bayer Affirms Safety Of YAZ / Yasmin And Refutes 2011 BMJ Articles About Risk Of Blood Clots

Another Rather "Odd" YAZ Label Change By Bayer: March 2011

YAZ / Yasmin / Ocella Litigation: February 2011 Update

YAZ And Yasmin MDL: First Trial In Federal Court Set By Judge Herndon To Start September 2011

August 2010 Status Update For The Yaz / Yasmin / Ocella Federal Court MDL Litigation

Is Bayer Warning Or Attacking With Its New YAZ / Yasmin Package Insert, Or Label, In The U.S

March 2010: Bayer Says It Will Update Yasmin Label In Europe To Add Results From Four Medical Studies

YAZ, Yasmin, Ocella: 1,100 Lawsuits Filed As Of Mid-February 2010, According To Bayer

Medical Journal Report: Adverse Drug Reactions And Pulmonary Embolism Are Often Difficult For Doctors To Diagnose

November 2009 Medical Journal Article Describes Large Ongoing Study About Safety Of YAZ

Yasmin And Yaz Birth Control Pills Are Under Scrutiny By Drug Regulators In Europe

Waiting For The Results From Swissmedic Safety Analysis Of Yaz And Other Drospirenone-Containing Contraceptives

October 2009: Yasmin And Yaz Multidistrict Litigation (MDL) Transfer Order For Injury And Death Cases Filed In Federal Court

Some Of The Drospirenone (DRSP) Progestin Used In Yaz And Yasmin Pills May Have Been Of Bad Quality

YAZ And Yasmin May Have Higher Risk Of Venous Thrombosis Than Older Birth Control Pills

A Theory Of How Yasmin Or YAZ Might Cause Pulmonary Embolism (PE) And Other Blood Clot Related Side Effects


WebMD List Of Symptoms For Serious Side Effects From Using Estrogen-Progestin Birth Control Methods

Yasmin / YAZ Multidistrict Litigation (MDL) Motion Filed In Late July 2009

Have Yasmin-Related Blood Clot Side Effect Cases Flown Below Radar In US?

Birth Control Pill YAZ Is Subject Of Ongoing Safety Study Regarding Cardiovascular Side Effects


Articles And News Reports About Yaz / Yasmin / Beyaz / Safyral / Ocella / Gianvi

 

Bayer Said to Pay $110 Million in Yaz Birth-Control Cases  

Bayer Birth-Control Pill May Boost Risks for Blood Clots

Group seeks re-vote on birth control clot risk

Bayer Judge Postpones First Yaz Trial to Have Cases Mediated

Grieving mother's warning about popular birth control pill

Bayer Birth Control Pill Benefits Outweigh Risks, Panel Says

FDA eyes stronger warning on popular birth control

Bayer Withheld Yasmin Data: Ex-FDA Head

Yasmin birth control lawsuit a 1st in Canada

Bayer May Have Pitched Birth-Control Pill for Unapproved Uses

Study: Yaz Has Higher Risks of Blood Clots

Yaz Birth Control Investigation: Nightline - ABC News (video)

Blood clots warning for women on the pill

U.S. Orders Review of Risks of Some Birth Control Pills

Birth-Control Pills With Drospirenone Raise Clot Risk in Study

Gallbladder risk no higher with newer Pills

Canadians launch birth control lawsuit

Pfleger's mother plans to sue contraceptive company Yaz

Mother of the late Michelle Pfleger asserts contraceptive contributed to her daughter's death

Watson Pharma gets approval for generic Yasmin

With Birth Control Pills, New Isn't Always Better

Bayer unbranded effort aims to counter bad birth control info

Bayer drops one infringement case v Teva over Yaz

Top-selling birth control pill in U.S.: Miracle drug or poison pill?

Yaz' sales reps must produce files for national litigation

Teva admits Gianvi label information was false: Bayer

Bayer Sues Teva, Barr Over Yaz Generic Contraceptive Tablets Gianvi

Teva Pharmaceutical launches generic Yaz

Actress Sues Bayer, Claims Birth Control Pill Caused Stroke at 27

Birth control pill concerns bring lawsuits but few solid answers

New safety label for birth control pills -- Bayer to include blood clot risks on Yaz and Yasmin packages

Calgarians join class action $15M lawsuit against birth control makers

Bayer Schering Pharma Set To Update Yasmin Label In EU

Yaz, Yasmin pills to remain on market

Montara woman sues drug company over birth control pills

Bayer Accused in Canadian Lawsuit of Hiding Yaz Risks

Family Claims Birth Control Pill Killed College Student

Indy woman speaks on birth control suit

Hoosier women sue Bayer over Yasmin pill

YAZ, Yasmin suits filed locally against Bayer

Bayer sued over birth control Yaz's risks

Pittsburgh Mother Joins Lawsuit Against Birth Control Pill

Birth Control: Bitter Pill

N.J. Court Weighing Mass Tort Status for Suits Over Birth Control Pills
Bayer

Bayer under pressure as birth control pills linked to blood clots

Bayer unit sued over contraceptives' side effects

Bayer’s Yaz Consumer’s Death Probed By Swiss Agency

Yaz contraceptive pill to stay on the market

Health Concerns Are Raised Over Use of Popular Contraceptives

FDA Warns Bayer Over German Manufacturing Plant

Women Should Take Safest Birth-Control Pill, Researchers Say

Thrombosis Risk with OCs Depends on Progestogen

Bayer Sued Over Safety of Popular Birth Control Pills


All content by attorney Tom Lamb


Go to Free Case Evaluation form >>

Read more on our Drospirenone (DRSP) Birth Control Pills Information Page >>



  • US FDA advises that you should not stop taking any prescription medication before talking to your doctor.
  • Reports of serious drug side effects should be made to the US FDA MedWatch program.
  • The prescription drug names are registered trademarks of the respective drug companies.
  • DrugInjuryLaw.com is not affiliated with any of the drug companies, nor US FDA.
Law Offices of Thomas J. Lamb, P.A.
Lumina Station Suite 225
1908 Eastwood Road
Wilmington, NC 28403
Tel: (910) 256-2971   Fax: (910) 256-2972
Toll Free: (800) 426-9535
email: ThomasJLamb@DrugInjuryLaw.com

Disclaimer